CSIMarket
 
Haemonetics Corporation  (HAE)
Other Ticker:  
 
 

Haemonetics Income Statement Quarterly

HAE


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 336.25 318.18 311.33 305.30
Revenue From Contract With Customer Excluding Assessed Tax - - - -
Other Revenue -0.38 -0.67 -0.07 -0.59
Total Revenue 335.87 317.51 311.27 305.25 304.71
Cost of Goods and Services Sold 158.00 147.00 144.00 149.00 146.00
Gross Profit 177.87 170.51 167.27 156.25 158.71
Selling, Administration, Marketing 111.71 104.90 93.49 -97.38 94.66
Gain (Loss) on Disposition of Business - - - 0.38 -
Depriciation & Amortization - - - 24.67 8.08
Research and Development Expense 13.27 12.67 12.65 -15.64 12.69
Goodwill and Intangible Asset Impairment - 10.42 - - -
Other operatinig exp. /-income - - - 208.97 -
Unusual Expense /-Income - - - - -
Amortization Of Acquired Intangible Assets 6.91 7.22 7.47 -32.64 -
Total operating costs including COS 289.89 282.21 257.61 269.99 261.43
Operating income/-loss 45.98 35.30 53.66 35.26 43.28
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal - - - -0.38 -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income 1.95 2.47 2.07 3.01 1.06
Total costs & expenses 291.84 284.68 259.68 272.62 262.48
Income /-loss before income taxes 44.03 32.83 51.59 32.63 42.22
Income taxes expenses/-benefit 12.79 7.92 10.55 3.24 9.28
Income after income taxes 31.24 24.91 41.04 29.38 32.94
Net income/-loss of other equity 0.00 - - - 0.00
Income/-loss from cont. Ops. 31.24 24.91 41.04 29.38 32.94
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 31.24 24.91 41.04 29.38 32.94
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 31.24 24.91 41.04 29.38 32.94
EBIT 44.03 32.83 51.59 32.63 42.22
EBITD 67.56 55.85 74.62 56.48 65.79
EBITDA 68.34 56.63 75.45 57.35 66.58


Per Share (GAAP Quarterly, in $) (Dec 30 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jul 01 2023)
I. Quarter
(Apr 01 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Basic EPS (excl. extra items) 0.62 0.49 0.81 0.58 0.65
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.62 0.49 0.81 0.58 0.65
Basic shares outstanding (Mill. of Units) 50.77 50.73 50.54 50.45 50.51
   EPS other shares - - - - -
Diluted Net EPS 0.61 0.48 0.80 0.58 0.64
Diluted average shares (Mill. of Units) 51.45 51.40 51.34 51.52 51.22
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com